The loss of TRPM3 ion channel activity in ME/CFS patients compared with HC is consistent with previous investigations (Cabanas et al. 2018, 2019a, 2019b, 2021). The gene discussed is TRPM3; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.